Burjeel Medical City administers first Givosiran treatment in UAE | Healthcare Asia Magazine
Photo from Envato

Burjeel Medical City administers first Givosiran treatment in UAE

The medication was given to a 21-year-old Emirati with a rare liver disease.

Burjeel Medical City, under the guidance of the Department of Health – Abu Dhabi (DoH), has administered Givosiran for the first time in the United Arab Emirates.

The medication was administered to a 21-year-old Emirati with acute intermittent hepatic porphyria, a rare genetic disorder that leads to the accumulation of toxic metabolites in the liver.

The treatment is delivered as a monthly injection, using small interfering RNA (siRNA) technology to lower toxic metabolite levels, said Asma Al Mannaei, Executive Director of the Health Life Science Sector at the DoH— Abu Dhabi.

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

Thomson Medical to open second fertility hub
The Singapore-based hospital operator has upgraded its hardware to meet patient needs.
Wearable tech is your heart’s new best friend
One specialist clinic in Singapore uses a Holter patch to cut face-to-face appointments.